98.38%
Lot
NOR-202608-427
Purity
98.75%
- Form
- Lyophilised powder
- Storage
- −20 °C, desiccated
- Stability
- 24 months
- CAS
- 137525-51-0
- Formula
- C62H98N16O22
- Molecular weight
- 1419.53 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
BPC-157
Pentadecapeptide · body protection compound fragment
£29
Vial massBPC157-5-NOR
1
79 vials in stock · dispatched within 24 h
A fifteen-residue partial sequence of human gastric juice protein BPC. Supplied as a white lyophilised powder, sealed under nitrogen in amber borosilicate vials. Each lot is released against RP-HPLC purity and UPLC-MS identity confirmation.
Cell migration assaysFibroblast modelsStructural NMR
Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.
Analysis
Certificate of analysis
UPLC-MS chromatogramJanoshik Analytical
Retention time (min)λ 214 nm
Purity98.75%
Specification ≥ 98.0%
- Lot
- NOR-202608-427
- Released
- 2026-08-24
- Mass expected
- 1419.53 Da
- Mass found
- 1419.29 Da
- Water (KF)
- 2.00%
- Endotoxin
- 0.092 EU/mg
- Appearance
- White lyophilisate
Primary structure
15 residues
Hover a residue for detail
- Formula
- C62H98N16O22
- Molecular weight
- 1419.53 g/mol
Interactive
Reconstitution
Vial mass
mL
mcg
Syringe
- Draw to
- 10.0 units
- Volume
- 0.100 mL
- Concentration
- 2.50 mg/mL
- Draws per vial
- 20
Arithmetic for BPC-157 at the values you entered. Not a protocol and not a dose recommendation. Research use only.
Handling
- On arrival
- Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
- Reconstitution
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- After reconstitution
- 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
- Shelf life
- 24 months lyophilised, desiccated and protected from light.